Introduction Welcome to the UCB Newsroom, your source for the latest updates, press releases, and stories that showcase our commitment to advancing science and improving patient lives.Stay informed about our recent breakthroughs, partnerships, and innovations through our features and news updates. Latest press releases The press releases are intended for media and financial analysts Press release 17 Jun 2026 UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI[®... Read More Press release 17 Jun 2026 UCB completes acquisition of Candid Therapeutics, strengthening next generation immunology pipeline Read More Press release 5 Jun 2026 New EULAR 2026 data show CIMZIA[®] (certolizumab pegol) delivered consistent effect in rheumatoid... Read More Interested in more? Access our media image selection or contact us for particular requests.The UCB media relations team responds to calls and emails from professional journalists only. View all downloadable resources Contact us
Press release 17 Jun 2026 UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI[®... Read More
Press release 17 Jun 2026 UCB completes acquisition of Candid Therapeutics, strengthening next generation immunology pipeline Read More
Press release 5 Jun 2026 New EULAR 2026 data show CIMZIA[®] (certolizumab pegol) delivered consistent effect in rheumatoid... Read More